These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 22595973)

  • 1. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP; Brind J; Tomar R; Hill S
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
    Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we know the benefits of a taurolidine lock in adult home parenteral nutrition patients with a low infection rate?
    Olthof ED; Broekman MM; Wanten GJ
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385. PubMed ID: 25883235
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
    J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [No Abstract]   [Full Text] [Related]  

  • 8. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients.
    Touré A; Lauverjat M; Peraldi C; Boncompain-Gerard M; Gelas P; Barnoud D; Chambrier C
    Clin Nutr; 2012 Aug; 31(4):567-70. PubMed ID: 22285029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolidine lock - experience from the West of Scotland.
    Cullis PS; McKee RF
    Clin Nutr; 2011 Jun; 30(3):399-400; author reply 401. PubMed ID: 21256637
    [No Abstract]   [Full Text] [Related]  

  • 12. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
    Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
    APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C; Poisson C; Talbotec C; Goulet O
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    Koldehoff M; Zakrzewski JL
    Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine in Pediatric Home Parenteral Nutrition Patients.
    Hulshof EC; Hanff LM; Olieman J; de Vette S; Driessen GJ; Meeussen C; Escher JC
    Pediatr Infect Dis J; 2017 Feb; 36(2):233-235. PubMed ID: 27846059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
    Nguyen T; Camins BC; Butler DA
    Am J Ther; 2024 Jul-Aug 01; 31(4):e398-e409. PubMed ID: 38710029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience.
    Wales PW; Kosar C; Carricato M; de Silva N; Lang K; Avitzur Y
    J Pediatr Surg; 2011 May; 46(5):951-6. PubMed ID: 21616259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ethanol lock therapy in pediatric patients on long-term parenteral nutrition.
    Pieroni KP; Nespor C; Ng M; Garcia M; Hurwitz M; Berquist WE; Kerner JA
    Nutr Clin Pract; 2013 Apr; 28(2):226-31. PubMed ID: 23232749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.